1Naschitz JE,Yeshurun D,Lev LM,Thromboembolism in cancer:changing trends[J].Cancer,1993,71(4):1384-1390.
2Levine MN,Prevention of thrombotic disorders in cancer patients undergoing chemotherapy[J].Thromb Haemostas,1997,78(1):133-136.
3Grignani G,paccdhiarini L,Pagliarino M.The possible role of bloos platelets in tumour growth and dissemination[J].Haematologica,1986,71(3):245-255.
4Shen VS,Pollak EW.Fatal Pulmonary embolism in cancer Patients:is heparin prophylaxis justified[J]?Southern Med J,1980,739(5):841-843.
5Pritchard KI,Paterson AHG,Paul NA,et al.Increased Thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer[J].J Clin Oncol,1996,14:2731-2737.
6Hull KD,Delmore T,Carter C,et al.Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis[J].N Engl J Med,1983,306(1):194-198.
7Rosendaal FR,Van Hylckama Vlieg A,Doggen CJM.Venous thrombosis in the elderly[J].J Thromb Haemost,2007,5(Suppl1):310-317.
8Bloma JW,Osanto S,Rosendaal FR.High risk of venous thrombosis in patients with pancreatic cancer:A cohort study of 202 patients[J].Eur J Cancer,2006,42(3):410-414.
9Prystowsky JB,Morasch MD,Eskandari MK,et al.Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients[J].Surg,2005,138(4):759-763.
10Susman E.NCCN issues first guidelines for deep vein thrombosis treatment in cancer patients[J].J Nati Cancer Inst,2006,98(8):515.
